Lixte Biotechnology Holdings, Inc. is a clinical-stage biopharmaceutical company, which engages in the business of developing a drug class called protein phosphatase 2A inhibitors. The company is headquartered in Boca Raton, Florida and currently employs 3 full-time employees. The company went IPO on 2007-09-21. The firm is focused on identifying new targets for cancer drug development and developing and commercializing cancer therapies. The Company’s product pipeline is primarily focused on inhibitors of protein phosphatase 2A, which is used to enhance cytotoxic agents, radiation, immune checkpoint blockers and other cancer therapies. The Company’s inhibitors of protein phosphatases have significant therapeutic potential for a broad range of cancers. The company is focused on the clinical development of a specific protein phosphatase inhibitor, LB-100. In addition, lead compounds of the LB-100 series have anti-cancer activity in animal models of glioblastoma multiforme, neuroblastoma, and medulloblastoma, all cancers of neural tissue. Its subsidiary, Liora Technologies Europe Ltd., offers electronically controlled proton therapy systems for treating tumors in various types of cancers.
LIXT stock price ended at $5 on Wednesday, after dropping 1.38%
On the latest trading day May 13, 2026, the stock price of LIXT fell by 1.38%, dropping from $5.09 to $5.00. During the session, the stock saw a volatility of 6.39%, with prices oscillating between a daily low of $4.85 and a high of $5.16. On the latest trading day, the trading volume for LIXT rose by 528 shares, despite the declining prices. This uptick in volume may signal heightened risk in the near term. In total, 40.9K shares were traded, with a market value of approximately $58.1M.
LIXT Technical Signals
Technical Signals Summary
Buy Signals 5
Neutral Signals 1
Sell Signals 1
Strong Sell
Sell
Neutral
Buy
Strong Buy
LIXT currently exhibits 5 buy signals and 1 sell signals. The stock has been in an downtrend since 12:00 AM, with a total price change of -3.1% during this period. Overall, the technical indicators point to a Strong Buy outlook for the mid-term.
Bullish/Bearish Signals for LIXT
Our algorithms analyze key indicators like moving averages, RSI, MACD, and trading volume to generate bullish and bearish signals for LIXT. These insights help you make informed investment decisions.
Follow-Up Questions
How do technical analysis indicators apply to LIXT?
According to technical analysis, Lixte Biotechnology Holdings Inc has an aggregate signal of Strong Buy. Lixte Biotechnology Holdings Inc has 5 Buy signals, 1 Neutral Signals and 1 sell signals.
What is the RSI for Lixte Biotechnology Holdings Inc?
The RSI for Lixte Biotechnology Holdings Inc is currently 73.38, indicating a overbought condition
What is Lixte Biotechnology Holdings Inc price for the next 12 months?
Lixte Biotechnology Holdings Inc LIXT price for the next 12 months is estimated at $0.
How high is Lixte Biotechnology Holdings Inc expected to go?
According to wall street analysts, Lixte Biotechnology Holdings Inc is expected to reach a high forecast of $0.